TCT-627 Novel Sirolimus Eluting Stent With Fusion Coating Technology to Address the “Diabetes Issue”: 2-Year Result of the en-ABL e-Registry
2019
Patients with diabetes mellitus (DM) have poorer outcomes after percutaneous coronary intervention than those without diabetes. We evaluate the 2-year safety and efficacy profile of the Abluminus DES+ in patients with diabetes within the population enrolled in the large multicenter en-ABL e-registry
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI